CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-12.38%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
868
New
52
Increased
314
Reduced
272
Closed
83
Top Buys
| 1 |
Procter & Gamble
PG
|
$37.1M |
| 2 |
Verizon
VZ
|
$26M |
| 3 |
Apple
AAPL
|
$25M |
| 4 |
Salesforce
CRM
|
$24.3M |
| 5 |
PepsiCo
PEP
|
$23.9M |
Top Sells
| 1 |
Waste Management
WM
|
$63.3M |
| 2 |
Microsoft
MSFT
|
$62.1M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
$55.6M |
| 4 |
Citigroup
C
|
$51.9M |
| 5 |
Johnson & Johnson
JNJ
|
$40.8M |
Sector Composition
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Boston Scientific
BSX
$159B
| $8.28M | 0.07% |
222,215
+146,361
| +193% | +$5.45M |
|
252
Okta
OKTA
$16.1B
| $8.26M | 0.07% |
91,356
+53,942
| +144% | +$4.88M |
|
253
TJX Companies
TJX
$155B
| $8.26M | 0.07% |
147,836
-484,239
| -77% | -$27M |
|
254
Copart
CPRT
$47B
| $8.19M | 0.07% |
301,504
+58,876
| +24% | +$1.6M |
|
255
PTC Therapeutics
PTCT
$4.55B
| $8.12M | 0.07% |
202,652
-70,722
| -26% | -$2.83M |
|
|
ACC
256
DELISTED
American Campus Communities, Inc.
ACC
| $8.09M | 0.07% |
125,501
+71,686
| +133% | +$4.62M |
|
257
Quest Diagnostics
DGX
$20.5B
| $8.06M | 0.07% |
60,646
+19,970
| +49% | +$2.66M |
|
258
Aflac
AFL
$57.2B
| $8.06M | 0.07% |
145,637
-106,417
| -42% | -$5.89M |
|
259
Kura Oncology
KURA
$713M
| $8.03M | 0.07% |
438,315
| – | – |
|
260
Ecopetrol
EC
$18.7B
| $7.96M | 0.07% |
733,400
-655,600
| -47% | -$7.12M |
|
261
Celldex Therapeutics
CLDX
$1.52B
| $7.84M | 0.06% |
290,794
+13,313
| +5% | +$359K |
|
262
Southern Copper
SCCO
$83.6B
| $7.83M | 0.06% |
165,076
-455,536
| -73% | -$21.6M |
|
263
Walmart
WMT
$801B
| $7.74M | 0.06% |
190,908
+152,640
| +399% | +$6.19M |
|
264
Jack Henry & Associates
JKHY
$11.8B
| $7.58M | 0.06% |
42,131
+3,637
| +9% | +$655K |
|
265
Pacira BioSciences
PCRX
$1.19B
| $7.57M | 0.06% |
129,901
-44,180
| -25% | -$2.58M |
|
266
ResMed
RMD
$40.6B
| $7.55M | 0.06% |
35,998
-6,897
| -16% | -$1.45M |
|
267
Veracyte
VCYT
$2.55B
| $7.54M | 0.06% |
378,663
| – | – |
|
|
MORF
268
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.49M | 0.06% |
344,933
+160,537
| +87% | +$3.48M |
|
|
MTOR
269
DELISTED
MERITOR, Inc.
MTOR
| $7.35M | 0.06% |
202,379
-71,995
| -26% | -$2.62M |
|
270
Tandem Diabetes Care
TNDM
$850M
| $7.34M | 0.06% |
124,074
+81,499
| +191% | +$4.82M |
|
271
Intellia Therapeutics
NTLA
$1.29B
| $7.31M | 0.06% |
141,275
+40,148
| +40% | +$2.08M |
|
272
Jefferies Financial Group
JEF
$13.1B
| $7.24M | 0.06% |
274,253
+256,446
| +1,440% | +$6.77M |
|
|
CDK
273
DELISTED
CDK Global, Inc.
CDK
| $7.24M | 0.06% |
+132,212
| New | +$7.24M |
|
274
Everest Group
EG
$14.3B
| $7.19M | 0.06% |
25,646
+19,528
| +319% | +$5.47M |
|
275
Exelon
EXC
$43.9B
| $7.1M | 0.06% |
156,677
+17,368
| +12% | +$787K |
|